MRI and 1H MRS of the breast: Presence of a choline peak as malignancy marker is related to k21 value of the tumor in patients with invasive ductal carcinoma

Breast Journal

Volumn 14, Issue 6, 2008, Pages 574-580

  Geraghty, Patricia R ^a   Van Den Bosch, Maurice A A J ^a,b   Spielman, Daniel M ^a   Hunjan, Sandeep ^a   Birdwell, Robyn L ^a   Fong, Katherine J ^a   Stables, Lara A ^a   Zakhour, Marowan ^a   Herfkens, Robert J ^a   Ikeda, Debra M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Breast cancer; K21 value; Magnetic resonance imaging; Proton MR spectroscopy

Indexed keywords

CHOLINE;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IN VIVO STUDY; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTON NUCLEAR MAGNETIC RESONANCE; ULTRASOUND;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CHOLINE; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; NEOPLASM INVASIVENESS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 55649089391     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2008.00650.x     Document Type: Article

References (23)

1. Orel SG, Schnall MD. MR imaging of the breast for detection, diagnosis, and staging of breast cancer. Radiology 2001 220 : 13 30.
2. Robson ME, Offit K. Breast MRI for women with hereditary cancer risk. JAMA 2004 292 : 1368 70.
3. Kriege M, Brekelmans CT, Boetes C, et al. Efficacy of MRI and mammography for breast-cancer screening in woman with familial or genetic predisposition. N Engl J Med 2004 351 : 427 37.
4. Daniel BL, Yen YF, Glover GH, et al. Breast disease: dynamic spiral MR imaging. Radiology 1998 209 : 499 509.
5. Liberman L, Morris EA, Lee MJ, et al. Breast lesions detected on MR imaging: features and positive predictive value. AJR Am J Roentgenol 2002 179 : 171 8.
6. Agoston AT, Daniel BL, Herfkens RJ, et al. Intensity-modulated parametric mapping for simultaneous display of rapid dynamic and high-spatial-resolution breast MR imaging data. Radiographics 2001 21 : 217 26.
7. Mariano MN, Van den Bosch MAAJ, Daniel BL, et al. Contrast-enhanced MRI of ductal carcinoma in situ: Characteristics of a new intensity-modulated parametric mapping technique correlated with hsitopathologic findings. J Magn Reson Imaging 2005 22 : 520 6.
8. Robinson SP, Barton SJ, McSheehy PM, Griffiths JR. Nuclear magnetic resonance spectroscopy of cancer. Br J Radiol 1997 70 : S60 9.
9. Jacobs MA, Barker PB, Argani P, et al. Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: a feasibility study. J Magn Reson Imaging 2005 21 : 23 8.
10. 1H MRS at 1.5T. Eur Radiol 2005 15 : 1037 43.
11. Bolan PJ, Nelson MT, Yee D, Garwood M. Imaging in breast cancer: Magnetic resonance spectroscopy. Breast Cancer Res 2005 7 : 149 52.
12. Jagannathan NR, Kumar M, Seenu V. Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br J Cancer 2001 84 : 1016 22.
13. Bartella L, Morris EA, Dershaw DD, et al. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study. Radiology 2006 239 : 686 92.
14. Castillo M, Kwock L. Clinical applications of proton magnetic resonance spectroscopy in the evaluation of common intracranial tumors. Top Magn Reson Imaging 1999 10 : 104 13.
15. Tse GM, Cheung HS, Pang LM, et al. Characterization of lesions of the breast with proton MR spectroscopy: comparison of carcinomas, benign lesions, and phyllodes tumors. AJR Am J Roentgenol 2003 181 : 1267 72.
16. Knopp MV, Weiss E, Sinn HP, et al. Pathophysiologic basis of contrast enhancement in breast tumors. J Magn Reson Imaging 1999 10 : 260 6.
17. Star-Lack J, Nelson SJ, Kurhanewicz J, Huang LR, Vigneron DB. Improved water and lipid suppression for 3D PRESS CSI using RF band selective inversion with gradient dephasing (BASING). Magn Reson Med 1997 38 : 311 21.
18. Ikeda DM, Hylton NM, Kinkel K, et al. Development, standardization, and testing of a lexicon for reporting contrast-enhanced breast magnetic resonance imaging studies. J Magn Reson Imaging 2001 13 : 889 95.
19. Yeung DK, Yang WT, Tse GM. Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases. Radiology 2002 225 : 190 7.
20. Gribbestad IS, Singstad TE, Nilsen G, et al. In vivo 1H MRS of normal breast and breast tumors using a dedicated double breast coil. J Magn Reson Imaging 1998 8 : 1191 7.
21. Merchant TE. MR spectroscopy of the breast. Magn Reson Imaging Clin N Am 1994 2 : 691 703.
22. 1H MR spectroscopy. J Magn Reson Imaging 1999 10 : 159 64.
23. Yeh ED. Characterization of breast lesions with proton MR spectroscopy. AJR Am J Roentgenol 2003 181 : 1273 4.